logo
This 1 thing is a 'worthy investment' in your health and wellness, executive coach says—even as costs rise

This 1 thing is a 'worthy investment' in your health and wellness, executive coach says—even as costs rise

CNBC04-06-2025
The probability of a recession occurring this year stands at around 40%, according to a report released by J.P. Morgan at the end of May. While it is a much lower estimate from even a month ago, consumers still have some reservations and some admit to experiencing economic anxiety.
At the same time, 82% of U.S. consumers consider wellness a top priority and continue to invest in it, according to an April report from Capital One Shopping.
Stevi Gable Carr predicts that consumers will begin to decide which health products are worth the investment and which are not, especially as costs remain high on items like eggs and President Trump's tariffs cause worry about "uncertainty" in the future. Gable Carr is the founder and CEO of WISe Wellness Guild, a consultancy and media agency with a focus on wellness.
"I think we might see a downturn in some wearables and maybe supplements that aren't tried and true or vetted or FDA-approved," she says.
"I think we are going to see a really big shift into things like mental health, the democratization of therapy."
Investing in wellness does not have to end in someone breaking the bank, Gable Carr, who is also an executive coach, tells CNBC Make It. Some investments stand out as a higher priority than others, and she believes mental health is one of them.
"If I were going to make one suggestion, prioritizing your mental health if you are feeling that's something that's going to be a challenge for you, I absolutely say is a worthy investment," Gable Carr says.
Giving the proper attention to your mental health, and investing in the necessary resources, is not something that Gable Carr thinks people should cut corners on.
"People are using ChatGPT and AI as a therapist. And while I think that is wonderful for scaling access to these types of things, I am still a bit skeptical about the replacement of a real human, being able to connect with you when you might be in a place of mental health crisis," she says.
"If I were going to put my money towards one thing, it would definitely be in working directly with a therapist or a counselor in any capacity."
Gable Carr finds that improving your mental health can lead to positive changes in your occupational health and financial health as well. When people don't view each of those three aspects as a "triangle relationship," it can lead to negative outcomes, she explains.
"In where we are today with the wealth gap, there's a lot of pressure for people to continue to grind, and they are abandoning a lot of other pieces of their life in order to go and try to make more so they can consume more," Gable Carr says.
"We've almost taken the human out of human , and we created human doings. I think that the human has not served us."
Connecting with a mental health professional isn't always easy financially, Gable Carr acknowledges. Even spending more time with loved ones and less time alone can have benefits for your happiness.
"I do think that art of gathering is going to be something that we really see in this next phase that is going to be prioritized," she says.
"Getting back to just connecting with one another, sitting down for dinner together again, not eating in our cars, not being on our cell phones all the time."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

Yahoo

time2 minutes ago

  • Yahoo

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

Yahoo

time32 minutes ago

  • Yahoo

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

Associated Press

time35 minutes ago

  • Associated Press

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store